Fate Therapeutics Reports First Quarter 2020 Financial Results and Highlights Operational Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. DSX
2. GNK
3. INTC
4. SPCX
5. III
6. TTEC
7. DAL
8. AWK
9. ATNI
10. SMG

Go back to Fate Therapeutics Reports First Quarter 2020 Financial Results and Highlights Operational Progress

Fate Therapeutics (FATE) Misses Q1 EPS by 5c

May 11, 2020 5:12 PM EDT

Fate Therapeutics (NASDAQ: FATE) reported Q1 EPS of ($0.44), $0.05 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $2.52 million versus the consensus estimate of $1.8 million.

We are encouraged by the resilience of our employees, our clinical trial investigators and participating patients,... More